Notice: Policy on Bioequivalence Standards for Highly Variable Drug Products (English, HTML)
Notice: Policy on Bioequivalence Standards for Highly Variable Drug Products: English HTML file. From Health Canada, updated Jun 2021. View metadata, licence and the direct download on CanQuery.
- Format
- HTML
- Access
- Original download only
- Publisher-reported update
- 2021-06-01
This Notice serves to inform sponsors of drug submissions pursuant to Division C.08 of the Food and Drug Regulations (that is [i.e.], new drug and abbreviated new drug submissions) of changes in Health Canada's comparative bioavailability requirements for drug products which exhibit large pharmacokinetic within-subject variation in extent of absorption, as measured by area under the concentration versus time curve (AUC).
Data overview
- Formats
- HTML
- File languages
- English
- Available actions
- Access original file